Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.

Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.

Item

http://www.wikidata.org/entity/Q33761124

Q33761124

about

Tissue factor and thrombin in sickle cell anemia The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis.Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-κB inhibitors.Mechanisms of enhanced thrombus formation in cerebral microvessels of mice expressing hemoglobin-S.Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease Inflammatory targets of therapy in sickle cell disease.Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Original Research: Diametric effects of hypoxia on pathophysiology of sickle cell disease in a murine model.NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors Novel therapies targeting the endothelium in sickle cell disease.Interplay between coagulation and vascular inflammation in sickle cell disease.Prothrombotic aspects of sickle cell disease.Association of circulating transcriptomic profiles with mortality in sickle cell disease.Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters.

P2860

Q27024887-73FF8020-7038-49E1-99EE-29811C08F8F4 Q33754648-CE6590AE-2470-49BE-B044-7328FE740207 Q34038874-C571EA42-3834-4935-A3D9-D14AF23A95EE Q34387239-D74C21D9-026B-49A3-A721-07D2545C7425 Q34924453-07F73283-9CCB-4615-B9E7-3BE427AE185F Q36106316-BA8E16EC-2CD5-48ED-A722-841233D667EB Q36385224-87C4EBC3-BAF9-4580-8AF2-05FF4389166C Q36596850-E07ADE2B-CB49-445D-93D2-8DFC7F11BCEB Q37033939-E44DB827-375A-476C-91B1-445DECC5DBB1 Q37107198-085BE054-373A-44BC-B273-4EE4DAFFC901 Q37215741-B2466835-540F-4CF7-8DCD-295F42822A15 Q37930655-9DD1E355-B601-40A2-99D0-EC44EF7C119A Q38099667-3BADC14A-FA46-4435-A92B-D6A08440F1BE Q38696998-C9AC1C83-50AC-47F8-A7E9-61493DA25527 Q38857629-6508266F-AEF7-40D7-A5EA-E8B275B2D260 Q38859913-C90FFEB7-1D20-4D34-A054-E81301EE34AD Q39821381-530727BD-6D1A-475D-AB36-DCA3ED3A0342 Q41996084-605166DB-EAF0-4E10-9DD9-87763FAA093C Q46081377-19682AFE-17B7-4D97-9BBC-7EA012FD9E68 Q47145599-3C512AAF-3D7A-4DEC-A34E-1E78D623EB86

P2860

Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.

Item

http://www.wikidata.org/entity/Q33761124

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu